Global Anti-Obesity Drugs Market 2015-2019

Global Anti-Obesity Drugs Market 2015-2019
Market , Share, Size, Trends, Analysis, Demand & Forecast to
2019
Report Description:
About Obesity
Obesity is a medical condition in which there is surplus accumulation of fat in the body. It is
linked with increased illness risk, disability, and death. Although anti-obesity drugs are
available in the market, their effectiveness is restricted to maintain weight rather than cure.
The Global Anti-obesity Drugs market to grow at a CAGR of 39.45 percent over the period
2014-2019. The Global Anti-obesity Drugs Market 2015-2019, has been prepared based on an
in-depth market analysis with inputs from industry experts
About
market
Report:
http://www.bigmarketresearch.com/global-anti-obesity-drugs-2015-2019-
Report Description:
Covered in this Report
The Global Anti-obesity Drugs market can be divided into two segments: Peripherally Acting
Anti-obesity Drugs and Centrally Acting Anti-obesity Drugs. This report covers the present
scenario and the growth prospects of the Global Anti-obesity Drugs market for the period
2014–2019. To calculate the market size, the report considers the revenue generated from the
sales of FDA approved drugs and OTC medications used in the treatment of obesity that are
available in the market.
The report covers the Americas, the APAC and EMEA regions; it also covers the Global Antiobesity Drugs market landscape and its growth prospects in the coming years. The report also
includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Regions:
Key Vendors
• Arena Pharmaceuticals
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Orexigen Therapeutics
• Vivus
Other Prominent Vendors
• Amylin
• Alizyme
• Boehringer Ingelheim
• Eisai
• Merck
• Norgine
• Novo Nordisk
• Pfizer
• Rhythm Pharmaceuticals
• Shionogi USA
• Takeda Pharmaceutical
• Zafgan
Key Regions:
Market Driver
• Increased Prevalence of Obesity
• For a full, detailed list, view our report
Market Challenge
• High Drug Development Costs
• For a full, detailed list, view our report
Market Trend
• Stiff Market Competition
• For a full, detailed list, view our report
Key Regions:
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Read more details at: http://www.bigmarketresearch.com/report-enquiry/169888
FOR MORE DETAILS
Visit us at :
http://www.bigmarketresearch.com/global-anti-obesitydrugs-2015-2019-market
Stay With Us:
TELEPHONE: + 1-800-910-6452
EMAIL:
help@bigmarketresearch.com
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States

Big Market Research present “Global Anti-Obesity Drugs Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-anti-obesity-drugs-2015-2019-market Obesity is a medical condition in which there is surplus accumulation of fat in the body. It is linked with increased illness risk, disability, and death. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure. The Global Anti-obesity Drugs market can be divided into two segments: Peripherally Acting Anti-obesity Drugs and Centrally Acting Anti-obesity Drugs.